SNORD3B-2

Across TCGA pan-cancer cohorts, SNORD3B-2 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SNORD3B-2 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher SNORD3B-2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SNORD3B-2 expression acts as an unfavorable survival marker.

BLCA are the cancer types where SNORD3B-2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.252	0.721	.001	27	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

SNORD3B-2–BLCA (OS)

Open the BLCA breakdown →